2,2'-azobis(2-amidinopropane) has been researched along with tamoxifen in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, LM; Custódio, JB; Dinis, TC; Madeira, VM | 1 |
| Adams, MR; Schwenke, DC; Wagner, JD | 1 |
| Almeida, LM; Cruz Silva, MM; Custódio, JB; Madeira, VM | 1 |
| Aschner, M; Feustel, PJ; Kimelberg, HK; Milatovic, D; Zhang, Y | 1 |
4 other study(ies) available for 2,2'-azobis(2-amidinopropane) and tamoxifen
| Article | Year |
|---|---|
Tamoxifen and hydroxytamoxifen as intramembraneous inhibitors of lipid peroxidation. Evidence for peroxyl radical scavenging activity.
Topics: Amidines; Animals; Ascorbic Acid; Azo Compounds; Ferrous Compounds; Free Radical Scavengers; Hydrogen Peroxide; Intracellular Membranes; Lipid Peroxidation; Nitriles; Oxygen Consumption; Rabbits; Sarcoplasmic Reticulum; Tamoxifen; Time Factors | 1994 |
In vitro lipid peroxidation of LDL from postmenopausal cynomolgus macaques treated with female hormones.
Topics: Alkenes; alpha-Tocopherol; Amidines; Animals; Cholesterol, HDL; Copper; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; gamma-Tocopherol; Lipid Peroxidation; Lipoproteins, LDL; Macaca fascicularis; Medroxyprogesterone Acetate; Molecular Weight; Multivariate Analysis; Tamoxifen | 1999 |
Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structure.
Topics: Adult; Amidines; Anemia, Hemolytic; Cells, Cultured; Dose-Response Relationship, Drug; Erythrocyte Membrane; Erythrocytes; Estrogen Antagonists; Hemolysis; Humans; Isotonic Solutions; Middle Aged; Osmotic Fragility; Oxidative Stress; Oxygen Consumption; Tamoxifen; Vitamin E | 2000 |
Neuroprotection by tamoxifen in focal cerebral ischemia is not mediated by an agonist action at estrogen receptors but is associated with antioxidant activity.
Topics: Amidines; Analysis of Variance; Animals; Antioxidants; Disease Models, Animal; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Estradiol; Estrogen Antagonists; F2-Isoprostanes; Fulvestrant; Functional Laterality; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Tamoxifen | 2007 |